<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">62101</article-id><article-id pub-id-type="doi">10.7554/eLife.62101</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Feature Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Science Forum: Improving preclinical studies through replications</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-204935"><name><surname>Drude</surname><given-names>Natascha I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7153-2894</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-204933"><name><surname>Martinez Gamboa</surname><given-names>Lorena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-204934"><name><surname>Danziger</surname><given-names>Meggie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210320"><name><surname>Dirnagl</surname><given-names>Ulrich</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0755-6119</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-204932"><name><surname>Toelch</surname><given-names>Ulf</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8731-3530</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Experimentelle Neurologie</institution>, <institution>Charité Universitätsmedizin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution content-type="dept">Department of Experimental Neurology</institution>, <institution>Charité Universitätsmedizin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><institution content-type="dept">BIH QUEST Center for Transforming Biomedical Research</institution>, <institution>Berlin Institute of Health</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1390"><name><surname>Rodgers</surname><given-names>Peter</given-names></name><role>Reviewing editor</role><aff><institution>eLife</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ulf.toelch@bihealth.de</email> (UT);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>12</day><month>01</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e62101</elocation-id><history><date date-type="received"><day>02</day><month>09</month><year>2020</year></date><date date-type="accepted"><day>12</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Drude et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Drude et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-62101-v1.pdf"/><abstract><p>The purpose of preclinical research is to inform the development of novel diagnostics or therapeutics, and the results of experiments on animal models of disease often inform the decision to conduct studies in humans. However, a substantial number of clinical trials fail, even when preclinical studies have apparently demonstrated the efficacy of a given intervention. A number of large-scale replication studies are currently trying to identify the factors that influence the robustness of preclinical research. Here, we discuss replications in the context of preclinical research trajectories, and argue that increasing validity should be a priority when selecting experiments to replicate and when performing the replication. We conclude that systematically improving three domains of validity – internal, external and translational – will result in a more efficient allocation of resources, will be more ethical, and will ultimately increase the chances of successful translation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>German Ministry for Education and Science</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Drude</surname><given-names>Natascha I</given-names></name><name><surname>Martinez Gamboa</surname><given-names>Lorena</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>No data was generated.</p></sec></sec></back></article>